Soft Tissue Neoplasms

Displaying 1 - 7 of 7CSV
Jang, E. S., Hammoor, B., Enneking, F. K., Chan, C. M., Spiguel, A. R., Gibbs, C. P., Scarborough, M. T., & Tyler, W. K. (2022). Effect of Insurance Status on Mortality in Adults With Sarcoma of the Extremities and Pelvis: A SEER-Medicare Study. Journal of the American Academy of Orthopaedic Surgeons, 31(1), e14–e22. https://doi.org/10.5435/jaaos-d-21-01071
Publication Date
Rosenbaum, E., Chugh, R., Ryan, C. W., Agulnik, M., Milhem, M. M., George, S., Jones, R. L., Chmielowski, B., Van Tine, B. A., Tawbi, H., Elias, A. D., Read, W. L., Budd, G. T., Qin, L.-X., Rodler, E. T., Hirman, J., Weiden, P., Bennett, C. M., Livingston, P. O., … Carvajal, R. D. (2022). A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery. European Journal of Cancer, 176, 155–163. https://doi.org/10.1016/j.ejca.2022.09.003
Publication Date
Kasper, B., D’Ambrosio, L., Davis, E. J., Ingham, M., Broto, J. M., Trent, J. C., van Houdt, W. J., & Van Tine, B. A. (2022). What Clinical Trials Are Needed for Treatment of Leiomyosarcoma? Current Treatment Options in Oncology, 23(3), 439–449. https://doi.org/10.1007/s11864-021-00928-y
Publication Date